Company intelligence / Profile preview
Innervate Radiopharmaceuticals
NJ, United Statesinnervaterp.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Innervate Radiopharmaceuticals develops radiopharmaceutical diagnostic and therapeutic agents targeting oncology and cardiovascular indications. Its lead program involves a PET imaging agent for neuroblastoma that has completed a Phase 3 trial. Another program targets heart failure/coronary disease in Phase 2. The company also offers contract manufacturing services for active pharmaceutical ingredients and radiopharmaceuticals.[2][5][6]
- Therapeutic areas
- OncologyCardiovascular
- Modalities
- Radiopharmaceuticals (diagnostic and therapeutic agents)Diagnostic agents for PET imaging[1][6][10]Anticancer pharmaceutical compounds[1]Biomarker reagents and companion diagnostics[1]
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Innervate Radiopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innervate Radiopharmaceuticals.